awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35904476-C4729567-3617-4FFC-BDA0-600450845967
Q35904476-C4729567-3617-4FFC-BDA0-600450845967
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35904476-C4729567-3617-4FFC-BDA0-600450845967
A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease.
P2860
Q35904476-C4729567-3617-4FFC-BDA0-600450845967
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35904476-C4729567-3617-4FFC-BDA0-600450845967
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2fb1395cbbc64ddbd312e2a4448434b090b2c15
P2860
The future of pharmacologic stress: selective A2A adenosine receptor agonists.